Michael Polansky, founder of Outer Biosciences, is leading an effort to train an AI model using living human tissue. The startup has successfully maintained this tissue outside the body for more than a month, a significant achievement in ex vivo biological research.
Polansky, a Harvard graduate in applied mathematics and computer science, has a diverse professional background. He spent three years at the hedge fund Bridgewater Associates before moving to Silicon Valley. He then worked as a principal at Founders Fund, a venture capital firm, alongside partners like Peter Thiel and Sean Parker.
After his time at Founders Fund, Polansky joined Sean Parker's family office, managing his business, investment, and philanthropic interests, including the Parker Institute for Cancer Immunotherapy, where he remains executive director. His current venture, Outer Biosciences, marks a shift into the intersection of AI and biology, focusing on the long-term viability of living tissues for research.
The ability to keep living human tissue alive for extended periods outside the body, combined with AI training, could offer new avenues for biological and medical research. This technology could potentially reduce the need for animal testing and accelerate drug discovery and understanding of human biology.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's briefNew every morning, and the back catalogue is archived by date.
Michael Polansky, founder of Outer Biosciences, is developing an AI model using living human tissue that the company has kept alive outside the body for over a month. This work focuses on combining AI and biology to advance research in maintaining biological systems ex vivo.